Company Performance Metrics
- Philippe Lassalle: Founder
Biothelis is a biotechnology company that specializes in the development and distribution of reagents for research on human and non-human endocan, including cleaved endocan. The company's product portfolio is designed to support scientific investigations into endocan as a diagnostic biomarker for endothelial response in various diseases.
Biothelis provides solutions such as the JDIYEK® ELISA Kit for endocan measurement and the fully automated Freedom EVO® ELISA 100 platform for endocan assay in an in vitro diagnostic (IVD) context. These offerings cater to laboratories, research institutes, and educational entities in life sciences, aiming to enhance patient care and prognosis in conditions like COVID-19 pneumonia through optimized management.